Matches in SemOpenAlex for { <https://semopenalex.org/work/W795816095> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- W795816095 endingPage "435" @default.
- W795816095 startingPage "421" @default.
- W795816095 abstract "The objective of this report is to introduce the European Union's variation rules governing medicinal products that are subject to post-approval changes. The EMEA outlines a variety of changes occurring to approved medicinal products. It also recommends a marketing authorisation holder to follow specific post-approval applications in various situations. For instance, the Commission Regulation(EC) No. 1085/2003 explains variation types and suggests post-authorisation procedures with which an applicant should comply. In all cases of minor and major variations the applicant has to investigate and validate whether or not the intended changes would have impact on the safety, efficacy and quality of a drug product. The applicant should then submit to the EMEA a variation application with adequate documentation in support of the notified changes. This procedure is implemented to ensure that changes to the approved medicinal product do not cause my public health concerns. In fact, the post-authorisation guidance categorizes post-approval changes into type IA/IB variations, type II variations, and extension applications. Such classifications determine administrative procedures to be followed in an efficient manner. Based on the type of a variation, the regulatory agency opts to reduce or extend the evaluation time-frame. The thrust of the EU's post-authorisation guidance is introduced in text with appropriate explanation. All these information will be likely to be helpful in updating a Korean regulatory guidance that could better deal with post-approval changes to generic drugs available in the market." @default.
- W795816095 created "2016-06-24" @default.
- W795816095 date "2006-12-21" @default.
- W795816095 modified "2023-10-14" @default.
- W795816095 title "Understanding Key Thrust of EMEA Post-Authorisation Guidance" @default.
- W795816095 doi "https://doi.org/10.4333/kps.2006.36.6.421" @default.
- W795816095 hasPublicationYear "2006" @default.
- W795816095 type Work @default.
- W795816095 sameAs 795816095 @default.
- W795816095 citedByCount "0" @default.
- W795816095 crossrefType "journal-article" @default.
- W795816095 hasConcept C108759981 @default.
- W795816095 hasConcept C112930515 @default.
- W795816095 hasConcept C144133560 @default.
- W795816095 hasConcept C26517878 @default.
- W795816095 hasConcept C38652104 @default.
- W795816095 hasConcept C41008148 @default.
- W795816095 hasConceptScore W795816095C108759981 @default.
- W795816095 hasConceptScore W795816095C112930515 @default.
- W795816095 hasConceptScore W795816095C144133560 @default.
- W795816095 hasConceptScore W795816095C26517878 @default.
- W795816095 hasConceptScore W795816095C38652104 @default.
- W795816095 hasConceptScore W795816095C41008148 @default.
- W795816095 hasIssue "6" @default.
- W795816095 hasLocation W7958160951 @default.
- W795816095 hasOpenAccess W795816095 @default.
- W795816095 hasPrimaryLocation W7958160951 @default.
- W795816095 hasRelatedWork W1794016765 @default.
- W795816095 hasRelatedWork W2329452785 @default.
- W795816095 hasRelatedWork W2356380379 @default.
- W795816095 hasRelatedWork W2363925233 @default.
- W795816095 hasRelatedWork W2364562957 @default.
- W795816095 hasRelatedWork W2364808845 @default.
- W795816095 hasRelatedWork W2366284060 @default.
- W795816095 hasRelatedWork W2391464953 @default.
- W795816095 hasRelatedWork W3027915305 @default.
- W795816095 hasRelatedWork W4206710999 @default.
- W795816095 hasVolume "36" @default.
- W795816095 isParatext "false" @default.
- W795816095 isRetracted "false" @default.
- W795816095 magId "795816095" @default.
- W795816095 workType "article" @default.